SG Americas Securities LLC Buys 97,173 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

SG Americas Securities LLC increased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 484.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,249 shares of the medical research company’s stock after buying an additional 97,173 shares during the quarter. SG Americas Securities LLC’s holdings in Thermo Fisher Scientific were worth $34,151,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Nuveen Asset Management LLC raised its position in Thermo Fisher Scientific by 10,824.0% in the 2nd quarter. Nuveen Asset Management LLC now owns 1,928,966 shares of the medical research company’s stock valued at $566,498,000 after purchasing an additional 1,911,308 shares during the last quarter. Jennison Associates LLC raised its position in Thermo Fisher Scientific by 2,589.9% in the 2nd quarter. Jennison Associates LLC now owns 819,138 shares of the medical research company’s stock valued at $240,564,000 after purchasing an additional 788,686 shares during the last quarter. Putnam Investments LLC raised its position in Thermo Fisher Scientific by 2,645.9% in the 2nd quarter. Putnam Investments LLC now owns 720,795 shares of the medical research company’s stock valued at $211,683,000 after purchasing an additional 694,545 shares during the last quarter. AQR Capital Management LLC raised its position in Thermo Fisher Scientific by 38.8% in the 2nd quarter. AQR Capital Management LLC now owns 2,141,471 shares of the medical research company’s stock valued at $621,561,000 after purchasing an additional 598,230 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in Thermo Fisher Scientific by 22.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,986,916 shares of the medical research company’s stock valued at $877,186,000 after purchasing an additional 555,802 shares during the last quarter. Institutional investors and hedge funds own 88.24% of the company’s stock.

Shares of NYSE TMO traded up $1.11 during midday trading on Friday, hitting $294.65. The stock had a trading volume of 787,876 shares, compared to its average volume of 1,323,858. The company’s 50-day simple moving average is $290.18 and its 200 day simple moving average is $283.40. The firm has a market cap of $117.34 billion, a P/E ratio of 26.50, a price-to-earnings-growth ratio of 1.90 and a beta of 1.14. Thermo Fisher Scientific Inc. has a fifty-two week low of $208.34 and a fifty-two week high of $306.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.80 and a quick ratio of 1.23.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 23rd. The medical research company reported $2.94 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.88 by $0.06. The company had revenue of $6.27 billion during the quarter, compared to analysts’ expectations of $6.19 billion. Thermo Fisher Scientific had a return on equity of 17.16% and a net margin of 14.24%. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same period last year, the firm earned $2.62 EPS. Equities analysts expect that Thermo Fisher Scientific Inc. will post 12.33 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 17th will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 6.83%.

In related news, Director Jim P. Manzi sold 1,833 shares of Thermo Fisher Scientific stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $272.93, for a total transaction of $500,280.69. Following the completion of the sale, the director now directly owns 28,592 shares of the company’s stock, valued at $7,803,614.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Marc N. Casper sold 47,729 shares of Thermo Fisher Scientific stock in a transaction on Friday, October 25th. The stock was sold at an average price of $295.88, for a total value of $14,122,056.52. Following the sale, the chief executive officer now directly owns 328,960 shares of the company’s stock, valued at $97,332,684.80. The disclosure for this sale can be found here. Insiders sold a total of 51,833 shares of company stock valued at $15,299,095 over the last three months. Insiders own 0.45% of the company’s stock.

Several brokerages have issued reports on TMO. JPMorgan Chase & Co. lifted their price objective on Thermo Fisher Scientific from $315.00 to $330.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Robert W. Baird lifted their price objective on Thermo Fisher Scientific from $305.00 to $319.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Needham & Company LLC lifted their price objective on Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. ValuEngine downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Barclays set a $330.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Monday, July 15th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $314.45.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: What is the CBOE Russell 2000® Volatility Index?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply